Abstract:Primary hypertension is a significant risk factor for cardiovascular diseases. However, the pathogenesis of primary hypertension involves multiple biological processes, including the nervous system, circulatory system, endocrine system, and more. Despite extensive research, there is no clear understanding of the regulatory mechanism underlying its pathogenesis. In recent years, miRNAs have gained attention as a regulatory factor capable of modulating the expression of related molecules through gene silencing. Therefore, exploring differentially expressed miRNAs in patients with essential hypertension (EH) may offer a novel approach for future diagnosis and treatment of EH. This study included a total of twenty Han Chinese population samples from Hefei, China. The samples consisted of 10 healthy individuals and 10 patients with EH. Statistical analysis was conducted to analyze the general information of the two-sample groups. High-throughput sequencing and base identification were performed to obtain the original sequencing sequences. These sequences were then annotated using various databases including Rfam, cDNA sequences, species repetitive sequences library, and miRBase database. The number of miRNA species contained in the samples was measured. Next, TPM values were calculated to determine the expression level of each miRNA. The bioinformatics of the differentiated miRNAs were analyzed using the OECloud tool, and RPM values were calculated. Furthermore, the reliability of the expression was analyzed by calculating the area under the Roc curve using the OECloud tools. Statistical analysis revealed no significant differences between the two samples in terms of age distribution, gender composition, smoking history, and alcohol consumption history ( P > 0.05). However, there was a notable presence of family genetic history and high BMI in the EH population ( P < 0.05). The sequencing results identified a total of 245 miRNAs, out of which 16 miRNAs exhibited differential expression. Among the highly expressed miRNAs were let-7d-5p, miR-101-3p, miR-122-5p, miR-122b-3p, miR-192-5p, and miR-6722-3p. On the other hand, the lowly expressed miRNAs included miR-103a-3p, miR-16-5p, miR-181a-2-3p, miR-200a-3p, miR-200b-3p, miR-200c-3p, miR-221-3p, miR-30d-5p, miR-342-5p, and miR-543. This study initially identified 16 miRNAs that are aberrantly expressed and function in various processes associated with the onset and progression of essential hypertension. These miRNAs have the potential to be targeted for future diagnosis and treatment of EH. However, further samples are required to provide additional support for this study.

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the differential expression of microRNAs (miRNAs) in the peripheral blood of patients with Essential Hypertension (EH), with the aim of identifying abnormally expressed miRNAs related to the occurrence and development of EH, thereby providing new targets for the future diagnosis and treatment of EH. Specifically, the researchers used high-throughput sequencing technology to detect the expression of miRNAs in the peripheral blood of 20 Han Chinese samples (10 healthy individuals and 10 EH patients), aiming to identify abnormally expressed miRNAs in EH patients and analyze their potential roles in the pathogenesis of EH. The study found that a total of 16 miRNAs exhibited differential expression in EH patients, with 6 being upregulated and 10 being downregulated. These miRNAs may be involved in the occurrence and development of EH by regulating the expression of related molecules and activating signaling pathways. The results lay the foundation for further exploration of the specific regulatory mechanisms of EH. However, the study also pointed out that due to the small sample size, future studies need to increase the sample size for larger-scale research to validate these findings.

Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China

Microarray Analysis of Differential Gene Expression Profile in Peripheral Blood Cells of Patients with Human Essential Hypertension

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

MICRORNAS AS BIOMARKERS IN THE DIFFERENTIATION OF HYPERTENSION CAUSED BY TAKAYASU ARTERITIS FROM ESSENTIAL HYPERTENSION

MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.

The diagnostic values of circulating microRNAs for hypertension and bioinformatic analysis.

Integrated Analysis of miRNA and mRNA Regulation Network in Hypertension

Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension

Differential Expression of Microrna in Endothelial Cells Incubated with Serum of Hypertension Patients with Blood-Stasis Syndrome

Expression profiles and potential functions of microRNAs in heart failure patients from the Uyghur population

Transcriptome Analysis of Arterial and Venous Circulating Mirnas During Hypertension

Abstract 13856: Circulating Microrna Differentiates HFpEF and HFrEF Patients

Signature Microrna Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection

The Diagnostic Values Of Circulating Mirnas For Hypertension And Bioinformatics Analysis

Associations Between Single Nucleotide Polymorphisms in Mir-221, Self-Reported Essential Hypertension, and Interactions Between Genetic and Environmental Factors: a Multiethnic Study in China.

MicroRNA-505 Identified from Patients with Essential Hypertension Impairs Endothelial Cell Migration and Tube Formation.

Circulating Mirna29 Family Expression Levels in Patients with Essential Hypertension As Potential Markers for Left Ventricular Hypertrophy

Association between single nucleotide polymorphisms in 3'UTR of ERAP1 gene and essential hypertension in Jilin Han population

Abstract 070: ONE UP-REGULATED NOVEL MICRORNA AND 4 DOWN-REGULATED MRNA TARGETS WERE IDENTIFIED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME

Combination of PBMC Mir-19B-5p, Mir-221, Mir-25-5p and Hypertension Correlates with Increased Risk of Heart Failure in Coronary Heart Disease Patients

Blood Microrna 202-3P Associates with the Risk of Essential Hypertension by Targeting Soluble ST2